These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

223 related items for PubMed ID: 17322097

  • 1. Targeting ligand-induced binding sites on GPIIb/IIIa via single-chain antibody allows effective anticoagulation without bleeding time prolongation.
    Stoll P, Bassler N, Hagemeyer CE, Eisenhardt SU, Chen YC, Schmidt R, Schwarz M, Ahrens I, Katagiri Y, Pannen B, Bode C, Peter K.
    Arterioscler Thromb Vasc Biol; 2007 May; 27(5):1206-12. PubMed ID: 17322097
    [Abstract] [Full Text] [Related]

  • 2. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
    Khaspekova SG, Vyzova TV, Lukin VV, Tikhomirov OIu, Berndt M, Kouns W, Mazurov AV.
    Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Targeting platelets in acute experimental stroke: impact of glycoprotein Ib, VI, and IIb/IIIa blockade on infarct size, functional outcome, and intracranial bleeding.
    Kleinschnitz C, Pozgajova M, Pham M, Bendszus M, Nieswandt B, Stoll G.
    Circulation; 2007 May 01; 115(17):2323-30. PubMed ID: 17438148
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Platelet-targeted thromboprophylaxis with a human serum albumin fusion drug: Preventing thrombosis and reducing cardiac ischemia/reperfusion injurywithout bleeding complications.
    Song Y, Bienvenu LA, Bongcaron V, Prijaya SA, Maluenda AC, Walsh APG, McFayden JD, Pietersz GA, Peter K, Wang X.
    Theranostics; 2024 May 01; 14(8):3267-3281. PubMed ID: 38855181
    [Abstract] [Full Text] [Related]

  • 11. Molecular magnetic resonance imaging allows the detection of activated platelets in a new mouse model of coronary artery thrombosis.
    Duerschmied D, Meißner M, Peter K, Neudorfer I, Roming F, Zirlik A, Bode C, von Elverfeldt D, von Zur Muhlen C.
    Invest Radiol; 2011 Oct 01; 46(10):618-23. PubMed ID: 21577120
    [Abstract] [Full Text] [Related]

  • 12. Novel Thrombolytic Drug Based on Thrombin Cleavable Microplasminogen Coupled to a Single-Chain Antibody Specific for Activated GPIIb/IIIa.
    Bonnard T, Tennant Z, Niego B, Kanojia R, Alt K, Jagdale S, Law LS, Rigby S, Medcalf RL, Peter K, Hagemeyer CE.
    J Am Heart Assoc; 2017 Feb 03; 6(2):. PubMed ID: 28159824
    [Abstract] [Full Text] [Related]

  • 13. [Preparation and characterization of a single chain antibody fragment of mAb SZ-21 against platelets GPIIIa].
    An G, Dong N, Shao B, Zhu M, Ruan C.
    Zhonghua Xue Ye Xue Za Zhi; 2002 Sep 03; 23(9):480-2. PubMed ID: 12482360
    [Abstract] [Full Text] [Related]

  • 14. Selective induction of a glycoprotein IIIa ligand-induced binding site by fibrinogen and von Willebrand factor.
    Mondoro TH, Wall CD, White MM, Jennings LK.
    Blood; 1996 Nov 15; 88(10):3824-30. PubMed ID: 8916946
    [Abstract] [Full Text] [Related]

  • 15. Recombinant anti-idiotypic antibodies inhibit human natural anti-glycoprotein (GP)IIb/IIIa autoantibodies.
    Escher R, Vogel M, Escher G, Miescher S, Stadler BM, Berchtold P.
    J Autoimmun; 2002 Feb 15; 18(1):71-81. PubMed ID: 11869049
    [Abstract] [Full Text] [Related]

  • 16. A novel regulatory epitope defined by a murine monoclonal antibody to the platelet GPIIb-IIIa complex (alpha IIb beta 3 integrin).
    Tokuhira M, Handa M, Kamata T, Oda A, Katayama M, Tomiyama Y, Murata M, Kawai Y, Watanabe K, Ikeda Y.
    Thromb Haemost; 1996 Dec 15; 76(6):1038-46. PubMed ID: 8972029
    [Abstract] [Full Text] [Related]

  • 17. Allicin and disulfiram enhance platelet integrin alphaIIbbeta3-fibrinogen binding.
    Manaster Y, Shenkman B, Rosenberg N, Savion N.
    Thromb Res; 2009 Sep 15; 124(4):477-82. PubMed ID: 19632706
    [Abstract] [Full Text] [Related]

  • 18. Delayed targeting of CD39 to activated platelet GPIIb/IIIa via a single-chain antibody: breaking the link between antithrombotic potency and bleeding?
    Hohmann JD, Wang X, Krajewski S, Selan C, Haller CA, Straub A, Chaikof EL, Nandurkar HH, Hagemeyer CE, Peter K.
    Blood; 2013 Apr 18; 121(16):3067-75. PubMed ID: 23380744
    [Abstract] [Full Text] [Related]

  • 19. The anti-platelet approach targeting the fibrinogen ligand of the GPIIB/IIIa receptor.
    Tsikaris V.
    J Pept Sci; 2004 Oct 18; 10(10):589-602. PubMed ID: 15526708
    [Abstract] [Full Text] [Related]

  • 20. Differential expression of a ligand induced binding site (LIBS) by GPIIb-IIIa ligand recognition peptides and parenteral antagonists.
    Jennings LK, Haga JH, Slack SM.
    Thromb Haemost; 2000 Dec 18; 84(6):1095-102. PubMed ID: 11154119
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.